GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » StemRIM Inc (TSE:4599) » Definitions » Net Cash per Share

StemRIM (TSE:4599) Net Cash per Share : 円145.46 (As of Jan. 2024)


View and export this data going back to 2019. Start your Free Trial

What is StemRIM Net Cash per Share?

Net Cash per Share is calculated as Cash, Cash Equivalents, Marketable Securities minus Total Liabilities minus Minority Interest and then divided by Shares Outstanding (EOP). StemRIM's Net Cash per Share for the quarter that ended in Jan. 2024 was 円145.46.

The historical rank and industry rank for StemRIM's Net Cash per Share or its related term are showing as below:

TSE:4599' s Price-to-Net-Cash Range Over the Past 10 Years
Min: 2.88   Med: 4.75   Max: 10.06
Current: 3.19

During the past 7 years, the highest Price-to-Net-Cash Ratio of StemRIM was 10.06. The lowest was 2.88. And the median was 4.75.

TSE:4599's Price-to-Net-Cash is ranked better than
58.52% of 851 companies
in the Biotechnology industry
Industry Median: 3.96 vs TSE:4599: 3.19

StemRIM Net Cash per Share Historical Data

The historical data trend for StemRIM's Net Cash per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

StemRIM Net Cash per Share Chart

StemRIM Annual Data
Trend Jul17 Jul18 Jul19 Jul20 Jul21 Jul22 Jul23
Net Cash per Share
Get a 7-Day Free Trial 54.30 180.38 169.23 146.25 162.32

StemRIM Quarterly Data
Apr19 Jul19 Oct19 Jan20 Apr20 Jul20 Oct20 Jan21 Apr21 Jul21 Oct21 Jan22 Apr22 Jul22 Oct22 Jan23 Apr23 Jul23 Oct23 Jan24
Net Cash per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 136.66 124.44 162.32 156.50 145.46

Competitive Comparison of StemRIM's Net Cash per Share

For the Biotechnology subindustry, StemRIM's Price-to-Net-Cash, along with its competitors' market caps and Price-to-Net-Cash data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


StemRIM's Price-to-Net-Cash Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, StemRIM's Price-to-Net-Cash distribution charts can be found below:

* The bar in red indicates where StemRIM's Price-to-Net-Cash falls into.



StemRIM Net Cash per Share Calculation

In the calculation of a company's Net Cash per Share, assets other than cash and short term investments are considered to be worth nothing. But the company has to pay its debt and other liabilities in full. This is an extremely conservative way of valuation. Most companies have negative Net Cash per Share. But sometimes a company's price may be lower than its net-cash.

StemRIM's Net Cash per Share for the fiscal year that ended in Jul. 2023 is calculated as

Net Cash per Share (A: Jul. 2023 )
=(Cash, Cash Equivalents, Marketable Securities-Total Liabilities-Minority Interest)/Shares Outstanding (EOP)
=(10217.764-336.024-0)/60.8775
=162.32

StemRIM's Net Cash per Share for the quarter that ended in Jan. 2024 is calculated as

Net Cash per Share (Q: Jan. 2024 )
=(Cash, Cash Equivalents, Marketable Securities-Total Liabilities-Minority Interest)/Shares Outstanding (EOP)
=(9183.94-242.671-0)/61.4697
=145.46

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


StemRIM  (TSE:4599) Net Cash per Share Explanation

Ben Graham invested in situations where the company's stock price was lower than its net-cash. He assigned some value to the company's other current asset. The value is called Net Current Asset Value (NCAV). One research study, covering the years 1970 through 1983 showed that portfolios picked at the beginning of each year, and held for one year, returned 29.4 percent, on average, over the 13-year period, compared to 11.5 percent for the S&P 500 Index. Other studies of Graham's strategy produced similar results.

You can find companies that are traded below their Net Current Asset Value (NCAV) with our Net-Net screener.


StemRIM Net Cash per Share Related Terms

Thank you for viewing the detailed overview of StemRIM's Net Cash per Share provided by GuruFocus.com. Please click on the following links to see related term pages.


StemRIM (TSE:4599) Business Description

Traded in Other Exchanges
N/A
Address
7-15 Ayato Bio Incubator 3rd floor, Ayato Asagi 7-chome, Prefecture Ibaraki City, Osaka, JPN, 567-0085
StemRIM Inc is a biotechnology company engaged in developing regeneration-guided medicines. The business activity of the group includes research, development, manufacture, and sales of pharmaceuticals and medical devices and products such as gene therapy that activate stem cells existing in the body and induce regeneration of damaged tissue.

StemRIM (TSE:4599) Headlines

No Headlines